Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Particle Sciences and Microfluidics have extended their collaboration with the placement of the Microfluidics Reaction Technology (MRT) system at Particle Sciences.
Subscribe to our email newsletter
Particle Sciences said that MRT technology combines a high shear, high pressure impinging jet processor with expert process development to generate results in bottom-up nanoparticle creation and continuous pharmaceutical manufacturing through crystallisation and chemical reactions.
Robert Lee, vice president of pharmaceutical development at Particle Sciences, said: “Particle Sciences is extremely pleased with the potential of MRT and we have successfully used it with several client-driven projects.”
Bill Kober, vice president of sales, Americas at Microfluidics, said: “According to a recent independent survey, approximately 80% of pharmaceutical companies are planning to invest in continuous manufacturing in 2010. MRT offers exclusive results. However, it requires more than a machine.
“Particle Sciences was chosen as an early site for the technology because of their deep knowledge around both pharmaceutical formulation and nanoparticle engineering. We are confident that their engineers are fully trained and capable of developing processes for customers which will meet their requirements.”